Glaukos Corp. (GKOS)
177.47
-2.88
(-1.60%)
USD |
NYSE |
Sep 04, 16:00
177.48
+0.01
(+0.01%)
Pre-Market: 20:00
Glaukos Cash and Short Term Investments (Annual) : 278.76M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 278.76M |
| December 31, 2024 | 318.92M |
| December 31, 2023 | 295.43M |
| December 31, 2022 | 352.70M |
| December 31, 2021 | 414.05M |
| December 31, 2020 | 404.37M |
| December 31, 2019 | 173.98M |
| Date | Value |
|---|---|
| December 31, 2018 | 140.49M |
| December 31, 2017 | 119.01M |
| December 31, 2016 | 95.84M |
| December 31, 2015 | 91.20M |
| December 31, 2014 | 2.364M |
| December 31, 2013 | 6.788M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Abbott Laboratories | 8.939B |
| Alphatec Holdings, Inc. | 160.81M |
| Artivion, Inc. | 64.91M |
| ICU Medical, Inc. | 307.96M |
| Insulet Corp. | 716.10M |